Involvement of regulations of nucleophosmin and nucleoporins in gambogic acid-induced apoptosis in Jurkat cells

Basic and Clinical Pharmacology and Toxicology

Volumn 103, Issue 6, 2008, Pages 530-537

  Shu, Wenxiu ^a   Chen, Yan ^a   Li, Rui ^a   Wu, Qing ^a   Cui, Guohui ^a   Ke, Wenjuan ^a   Chen, Zi ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GAMBOGIC ACID; NUCLEOPHOSMIN; NUCLEOPORIN; NUCLEOPORIN 98; PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN NUP214; PROTEIN NUP88; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CONTROLLED STUDY; CYTOPLASM; GROWTH DISORDER; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL PROLIFERATION; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; HUMANS; JURKAT CELLS; NUCLEAR PORE COMPLEX PROTEINS; NUCLEAR PROTEINS; XANTHONES;

GARCINIA;

EID: 56049124594     PISSN: 17427835     EISSN: 17427843     Source Type: Journal    
DOI: 10.1111/j.1742-7843.2008.00292.x     Document Type: Article

References (27)

1. Yu J, Guo QL, You QD, Lin SS, Li Z, Gu HY et al. Repression of telomerase reverse transcriptase mRNA and hTERT promoter by gambogic acid in human gastric carcinoma cells. Cancer Chemother Pharmacol 2006 58 : 434 43.
2. Kasibhatla S, Jessen KA, Maliartchouk S, Wang JY, English NM, Drewe J et al. A role for transferrin receptor in triggering apoptosis when targeted with gambogic acid. Proc Natl Acad Sci USA 2005 102 : 12095 100.
3. Zhao L, Guo QL, You QD, Wu ZQ, Gu HY. Gambogic acid induces apoptosis and regulates expressions of Bax and Bcl-2 protein in human gastric carcinoma MGC-803 cells. Biol Pharm Bull 2004 27 : 998 1003.
4. Grisendi S, Mecucci C, Falini B, Pandolfi PP. Nucleophosmin and cancer. Nat Rev Cancer 2006 6 : 493 505.
5. Falini B, Mecucci C, Tiacci E, Alcalay M, Rosati R, Pasqualucci L et al. Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype. N Engl J Med 2005 352 : 254 66.
6. Ye K. Nucleophosmin/B23, a multifunctional protein that can regulate apoptosis. Cancer Biol Ther 2005 4 : 918 23.
7. Yu Y, Maggi LB Jr., Brady SN, Apicelli AJ, Dai MS, Lu H et al. Nucleophosmin is essential for ribosomal protein L5 nuclear export. Mol Cell Biol 2006 26 : 3798 809.
8. Hsu CY, Yung BY. Over-expression of nucleophosmin/B23 decreases the susceptibility of human leukemia HL-60 cells to retinoic acid-induced differentiation and apoptosis. Int J Cancer 2000 88 : 392 400.
9. Liu WH, Yung BY. Mortalization of human promyelocytic leukemia HL-60 cells to be more susceptible to sodium butyrate-induced apoptosis and inhibition of telomerase activity by down-regulation of nucleophosmin/B23. Oncogene 1998 17 : 3055 64.
10. Hsu CY, Yung BY. Involvement of nucleophosmin/B23 in TPA-induced megakaryocytic differentiation of K562 cells. Br J Cancer 2003 89 : 1320 6.
11. Romana SP, Radford-Weiss I, Ben Abdelali R, Schluth C, Petit A, Dastugue N et al. NUP98 rearrangements in hematopoietic malignancies: a study of the Groupe Francophone de Cytogenetique Hematologique. Leukemia 2006 20 : 696 706.
12. Garcon L, Libura M, Delabesse E, Valensi F, Asnafi V, Berger C et al. DEK-CAN molecular monitoring of myeloid malignancies could aid therapeutic stratification. Leukemia 2005 19 : 1338 44.
13. Burmeister T, Gokbuget N, Reinhardt R, Rieder H, Hoelzer D, Schwartz S. NUP214-ABL1 in adult T-ALL: the GMALL study group experience. Blood 2006 108 : 3556 9.
14. Fornerod M, Boer J, van Baal S, Morreau H, Grosveld G. Interaction of cellular proteins with the leukemia specific fusion proteins DEK-CAN and SET-CAN and their normal counterpart, the nucleoporin CAN. Oncogene 1996 13 : 1801 8.
15. Lee SH, Hannink M. Molecular mechanisms that regulate transcription factor localization suggest new targets for drug development. Adv Drug Deliv Rev 2003 55 : 717 31.
16. Fabbro M, Henderson BR. Regulation of tumor suppressors by nuclear-cytoplasmic shuttling. Exp Cell Res 2003 282 : 59 69.
17. Kau TR, Way JC, Silver PA. Nuclear transport and cancer: from mechanism to intervention. Nat Rev Cancer 2004 4 : 106 17.
18. Fahrenkrog B. The nuclear pore complex, nuclear transport, and apoptosis. Can J Physiol Pharmacol 2006 84 : 279 86.
19. Ferrando-May E. Nucleocytoplasmic transport in apoptosis. Cell Death Differ 2005 12 : 1263 76.
20. Yun JP, Chew EC, Liew CT, Chan JY, Jin ML, Ding MX et al. Nucleophosmin/B23 is a proliferate shuttle protein associated with nuclear matrix. J Cell Biochem 2003 90 : 1140 8.
21. Cronshaw JM, Krutchinsky AN, Zhang W, Chait BT, Matunis MJ. Proteomic analysis of the mammalian nuclear pore complex. J Cell Biol 2002 158 : 915 27.
22. Rout MP, Aitchison JD, Suprapto A, Hjertaas K, Zhao Y, Chait BT. The yeast nuclear pore complex: composition, architecture, and transport mechanism. J Cell Biol 2000 148 : 635 51.
23. Martinez N, Alonso A, Moragues MD, Ponton J, Schneider J. The nuclear pore complex protein NUP88 is overexpressed in tumor cells. Cancer Res 1999 59 : 5408 11.
24. Gould VE, Orucevic A, Zentgraf H, Gattuso P, Martinez N, Alonso A. NUP88 (karyoporin) in human malignant neoplasms and dysplasias: correlations of immunostaining of tissue sections, cytologic smears, and immunoblot analysis. Hum Pathol 2002 33 : 536 44.
25. Liu HL, Chen Y, Cui GH, Wu QL, He J, Chen WH et al. Deguelin regulates nuclear pore complex proteins NUP98 and NUP88 in U937 cells in vitro. Acta Pharmacol Sin 2005 26 : 1265 73.
26. Griffis ER, Altan N, Lippincott-Schwartz J, Powers MA. NUP98 is a mobile nucleoporin with transcription-dependent dynamics. Mol Biol Cell 2002 13 : 1282 97.
27. Griffis ER, Craige B, Dimaano C, Ullman KS, Powers MA. Distinct functional domains within nucleoporins NUP153 and NUP98 mediate transcription-dependent mobility. Mol Biol Cell 2004 15 : 1991 2002.